HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,644,628 | +160.7% | 263,797 | +179.9% | 0.00% | – |
| Q2 2023 | $3,316,481 | +110.4% | 94,245 | +95.2% | 0.00% | – |
| Q1 2023 | $1,576,636 | +102.9% | 48,289 | +242.5% | 0.00% | – |
| Q4 2022 | $776,910 | -65.3% | 14,100 | -72.1% | 0.00% | – |
| Q3 2022 | $2,241,000 | +9.6% | 50,594 | +20.7% | 0.00% | – |
| Q2 2022 | $2,044,000 | +333.1% | 41,911 | +332.5% | 0.00% | – |
| Q1 2022 | $472,000 | -25.1% | 9,690 | -34.3% | 0.00% | – |
| Q4 2021 | $630,000 | +38.2% | 14,752 | +6.9% | 0.00% | – |
| Q1 2021 | $456,000 | – | 13,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |